Zeskind Benjamin J. 4
4 · Immuneering Corp · Filed Feb 9, 2024
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option
2024-02-08+16,414→ 16,414 totalExercise: $6.70Exp: 2029-02-08→ Class A Common Stock (16,414 underlying) - Award
Stock Option
2024-02-08+244,286→ 244,286 totalExercise: $6.09Exp: 2034-02-08→ Class A Common Stock (244,286 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028.